Global Hereditary Angioedema Treatment Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Hereditary Angioedema Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hereditary Angioedema Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hereditary Angioedema Treatment market in any manner.
Global Hereditary Angioedema Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CSL
Pharming Group
Shire plc (Takeda Pharmaceutical Company Limited)
Ionis Pharmaceuticals
Attune Pharmaceuticals
BioCryst Pharmaceuticals
KalVista Pharmaceuticals
Market Segmentation (by Type)
C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Kallikrein Inhibitors (Kalbitor, Takhzyro)
Others (Conventional Drugs, Pipeline Drugs)
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Others (online pharmacies, mail pharmacies)
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hereditary Angioedema Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Hereditary Angioedema Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hereditary Angioedema Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hereditary Angioedema Treatment market in any manner.
Global Hereditary Angioedema Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CSL
Pharming Group
Shire plc (Takeda Pharmaceutical Company Limited)
Ionis Pharmaceuticals
Attune Pharmaceuticals
BioCryst Pharmaceuticals
KalVista Pharmaceuticals
Market Segmentation (by Type)
C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Kallikrein Inhibitors (Kalbitor, Takhzyro)
Others (Conventional Drugs, Pipeline Drugs)
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Others (online pharmacies, mail pharmacies)
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Hereditary Angioedema Treatment Market
- Overview of the regional outlook of the Hereditary Angioedema Treatment Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hereditary Angioedema Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Hereditary Angioedema Treatment
1.2 Key Market Segments
1.2.1 Hereditary Angioedema Treatment Segment by Type
1.2.2 Hereditary Angioedema Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HEREDITARY ANGIOEDEMA TREATMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hereditary Angioedema Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Hereditary Angioedema Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HEREDITARY ANGIOEDEMA TREATMENT MARKET COMPETITIVE LANDSCAPE
3.1 Global Hereditary Angioedema Treatment Sales by Manufacturers (2019-2024)
3.2 Global Hereditary Angioedema Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hereditary Angioedema Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Hereditary Angioedema Treatment Sales Sites, Area Served, Product Type
3.6 Hereditary Angioedema Treatment Market Competitive Situation and Trends
3.6.1 Hereditary Angioedema Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hereditary Angioedema Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HEREDITARY ANGIOEDEMA TREATMENT INDUSTRY CHAIN ANALYSIS
4.1 Hereditary Angioedema Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HEREDITARY ANGIOEDEMA TREATMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HEREDITARY ANGIOEDEMA TREATMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hereditary Angioedema Treatment Sales Market Share by Type (2019-2024)
6.3 Global Hereditary Angioedema Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Hereditary Angioedema Treatment Price by Type (2019-2024)
7 HEREDITARY ANGIOEDEMA TREATMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hereditary Angioedema Treatment Market Sales by Application (2019-2024)
7.3 Global Hereditary Angioedema Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Hereditary Angioedema Treatment Sales Growth Rate by Application (2019-2024)
8 HEREDITARY ANGIOEDEMA TREATMENT MARKET SEGMENTATION BY REGION
8.1 Global Hereditary Angioedema Treatment Sales by Region
8.1.1 Global Hereditary Angioedema Treatment Sales by Region
8.1.2 Global Hereditary Angioedema Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Hereditary Angioedema Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hereditary Angioedema Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hereditary Angioedema Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hereditary Angioedema Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hereditary Angioedema Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 CSL
9.1.1 CSL Hereditary Angioedema Treatment Basic Information
9.1.2 CSL Hereditary Angioedema Treatment Product Overview
9.1.3 CSL Hereditary Angioedema Treatment Product Market Performance
9.1.4 CSL Business Overview
9.1.5 CSL Hereditary Angioedema Treatment SWOT Analysis
9.1.6 CSL Recent Developments
9.2 Pharming Group
9.2.1 Pharming Group Hereditary Angioedema Treatment Basic Information
9.2.2 Pharming Group Hereditary Angioedema Treatment Product Overview
9.2.3 Pharming Group Hereditary Angioedema Treatment Product Market Performance
9.2.4 Pharming Group Business Overview
9.2.5 Pharming Group Hereditary Angioedema Treatment SWOT Analysis
9.2.6 Pharming Group Recent Developments
9.3 Shire plc (Takeda Pharmaceutical Company Limited)
9.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Basic Information
9.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Overview
9.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Market Performance
9.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment SWOT Analysis
9.3.5 Shire plc (Takeda Pharmaceutical Company Limited) Business Overview
9.3.6 Shire plc (Takeda Pharmaceutical Company Limited) Recent Developments
9.4 Ionis Pharmaceuticals
9.4.1 Ionis Pharmaceuticals Hereditary Angioedema Treatment Basic Information
9.4.2 Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Overview
9.4.3 Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Market Performance
9.4.4 Ionis Pharmaceuticals Business Overview
9.4.5 Ionis Pharmaceuticals Recent Developments
9.5 Attune Pharmaceuticals
9.5.1 Attune Pharmaceuticals Hereditary Angioedema Treatment Basic Information
9.5.2 Attune Pharmaceuticals Hereditary Angioedema Treatment Product Overview
9.5.3 Attune Pharmaceuticals Hereditary Angioedema Treatment Product Market Performance
9.5.4 Attune Pharmaceuticals Business Overview
9.5.5 Attune Pharmaceuticals Recent Developments
9.6 BioCryst Pharmaceuticals
9.6.1 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Basic Information
9.6.2 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Overview
9.6.3 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Market Performance
9.6.4 BioCryst Pharmaceuticals Business Overview
9.6.5 BioCryst Pharmaceuticals Recent Developments
9.7 KalVista Pharmaceuticals
9.7.1 KalVista Pharmaceuticals Hereditary Angioedema Treatment Basic Information
9.7.2 KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Overview
9.7.3 KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Market Performance
9.7.4 KalVista Pharmaceuticals Business Overview
9.7.5 KalVista Pharmaceuticals Recent Developments
10 HEREDITARY ANGIOEDEMA TREATMENT MARKET FORECAST BY REGION
10.1 Global Hereditary Angioedema Treatment Market Size Forecast
10.2 Global Hereditary Angioedema Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hereditary Angioedema Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Hereditary Angioedema Treatment Market Size Forecast by Region
10.2.4 South America Hereditary Angioedema Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hereditary Angioedema Treatment by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Hereditary Angioedema Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Hereditary Angioedema Treatment by Type (2025-2030)
11.1.2 Global Hereditary Angioedema Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Hereditary Angioedema Treatment by Type (2025-2030)
11.2 Global Hereditary Angioedema Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Hereditary Angioedema Treatment Sales (Kilotons) Forecast by Application
11.2.2 Global Hereditary Angioedema Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Hereditary Angioedema Treatment
1.2 Key Market Segments
1.2.1 Hereditary Angioedema Treatment Segment by Type
1.2.2 Hereditary Angioedema Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HEREDITARY ANGIOEDEMA TREATMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hereditary Angioedema Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Hereditary Angioedema Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HEREDITARY ANGIOEDEMA TREATMENT MARKET COMPETITIVE LANDSCAPE
3.1 Global Hereditary Angioedema Treatment Sales by Manufacturers (2019-2024)
3.2 Global Hereditary Angioedema Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hereditary Angioedema Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Hereditary Angioedema Treatment Sales Sites, Area Served, Product Type
3.6 Hereditary Angioedema Treatment Market Competitive Situation and Trends
3.6.1 Hereditary Angioedema Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hereditary Angioedema Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HEREDITARY ANGIOEDEMA TREATMENT INDUSTRY CHAIN ANALYSIS
4.1 Hereditary Angioedema Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HEREDITARY ANGIOEDEMA TREATMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HEREDITARY ANGIOEDEMA TREATMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hereditary Angioedema Treatment Sales Market Share by Type (2019-2024)
6.3 Global Hereditary Angioedema Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Hereditary Angioedema Treatment Price by Type (2019-2024)
7 HEREDITARY ANGIOEDEMA TREATMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hereditary Angioedema Treatment Market Sales by Application (2019-2024)
7.3 Global Hereditary Angioedema Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Hereditary Angioedema Treatment Sales Growth Rate by Application (2019-2024)
8 HEREDITARY ANGIOEDEMA TREATMENT MARKET SEGMENTATION BY REGION
8.1 Global Hereditary Angioedema Treatment Sales by Region
8.1.1 Global Hereditary Angioedema Treatment Sales by Region
8.1.2 Global Hereditary Angioedema Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Hereditary Angioedema Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hereditary Angioedema Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hereditary Angioedema Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hereditary Angioedema Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hereditary Angioedema Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 CSL
9.1.1 CSL Hereditary Angioedema Treatment Basic Information
9.1.2 CSL Hereditary Angioedema Treatment Product Overview
9.1.3 CSL Hereditary Angioedema Treatment Product Market Performance
9.1.4 CSL Business Overview
9.1.5 CSL Hereditary Angioedema Treatment SWOT Analysis
9.1.6 CSL Recent Developments
9.2 Pharming Group
9.2.1 Pharming Group Hereditary Angioedema Treatment Basic Information
9.2.2 Pharming Group Hereditary Angioedema Treatment Product Overview
9.2.3 Pharming Group Hereditary Angioedema Treatment Product Market Performance
9.2.4 Pharming Group Business Overview
9.2.5 Pharming Group Hereditary Angioedema Treatment SWOT Analysis
9.2.6 Pharming Group Recent Developments
9.3 Shire plc (Takeda Pharmaceutical Company Limited)
9.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Basic Information
9.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Overview
9.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Market Performance
9.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment SWOT Analysis
9.3.5 Shire plc (Takeda Pharmaceutical Company Limited) Business Overview
9.3.6 Shire plc (Takeda Pharmaceutical Company Limited) Recent Developments
9.4 Ionis Pharmaceuticals
9.4.1 Ionis Pharmaceuticals Hereditary Angioedema Treatment Basic Information
9.4.2 Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Overview
9.4.3 Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Market Performance
9.4.4 Ionis Pharmaceuticals Business Overview
9.4.5 Ionis Pharmaceuticals Recent Developments
9.5 Attune Pharmaceuticals
9.5.1 Attune Pharmaceuticals Hereditary Angioedema Treatment Basic Information
9.5.2 Attune Pharmaceuticals Hereditary Angioedema Treatment Product Overview
9.5.3 Attune Pharmaceuticals Hereditary Angioedema Treatment Product Market Performance
9.5.4 Attune Pharmaceuticals Business Overview
9.5.5 Attune Pharmaceuticals Recent Developments
9.6 BioCryst Pharmaceuticals
9.6.1 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Basic Information
9.6.2 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Overview
9.6.3 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Market Performance
9.6.4 BioCryst Pharmaceuticals Business Overview
9.6.5 BioCryst Pharmaceuticals Recent Developments
9.7 KalVista Pharmaceuticals
9.7.1 KalVista Pharmaceuticals Hereditary Angioedema Treatment Basic Information
9.7.2 KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Overview
9.7.3 KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Market Performance
9.7.4 KalVista Pharmaceuticals Business Overview
9.7.5 KalVista Pharmaceuticals Recent Developments
10 HEREDITARY ANGIOEDEMA TREATMENT MARKET FORECAST BY REGION
10.1 Global Hereditary Angioedema Treatment Market Size Forecast
10.2 Global Hereditary Angioedema Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hereditary Angioedema Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Hereditary Angioedema Treatment Market Size Forecast by Region
10.2.4 South America Hereditary Angioedema Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hereditary Angioedema Treatment by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Hereditary Angioedema Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Hereditary Angioedema Treatment by Type (2025-2030)
11.1.2 Global Hereditary Angioedema Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Hereditary Angioedema Treatment by Type (2025-2030)
11.2 Global Hereditary Angioedema Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Hereditary Angioedema Treatment Sales (Kilotons) Forecast by Application
11.2.2 Global Hereditary Angioedema Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hereditary Angioedema Treatment Market Size Comparison by Region (M USD)
Table 5. Global Hereditary Angioedema Treatment Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Hereditary Angioedema Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Hereditary Angioedema Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Hereditary Angioedema Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Treatment as of 2022)
Table 10. Global Market Hereditary Angioedema Treatment Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Hereditary Angioedema Treatment Sales Sites and Area Served
Table 12. Manufacturers Hereditary Angioedema Treatment Product Type
Table 13. Global Hereditary Angioedema Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hereditary Angioedema Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hereditary Angioedema Treatment Market Challenges
Table 22. Global Hereditary Angioedema Treatment Sales by Type (Kilotons)
Table 23. Global Hereditary Angioedema Treatment Market Size by Type (M USD)
Table 24. Global Hereditary Angioedema Treatment Sales (Kilotons) by Type (2019-2024)
Table 25. Global Hereditary Angioedema Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Hereditary Angioedema Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Hereditary Angioedema Treatment Market Size Share by Type (2019-2024)
Table 28. Global Hereditary Angioedema Treatment Price (USD/Ton) by Type (2019-2024)
Table 29. Global Hereditary Angioedema Treatment Sales (Kilotons) by Application
Table 30. Global Hereditary Angioedema Treatment Market Size by Application
Table 31. Global Hereditary Angioedema Treatment Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Hereditary Angioedema Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Hereditary Angioedema Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Hereditary Angioedema Treatment Market Share by Application (2019-2024)
Table 35. Global Hereditary Angioedema Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Hereditary Angioedema Treatment Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Hereditary Angioedema Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Hereditary Angioedema Treatment Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Hereditary Angioedema Treatment Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Hereditary Angioedema Treatment Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Hereditary Angioedema Treatment Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Hereditary Angioedema Treatment Sales by Region (2019-2024) & (Kilotons)
Table 43. CSL Hereditary Angioedema Treatment Basic Information
Table 44. CSL Hereditary Angioedema Treatment Product Overview
Table 45. CSL Hereditary Angioedema Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. CSL Business Overview
Table 47. CSL Hereditary Angioedema Treatment SWOT Analysis
Table 48. CSL Recent Developments
Table 49. Pharming Group Hereditary Angioedema Treatment Basic Information
Table 50. Pharming Group Hereditary Angioedema Treatment Product Overview
Table 51. Pharming Group Hereditary Angioedema Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Pharming Group Business Overview
Table 53. Pharming Group Hereditary Angioedema Treatment SWOT Analysis
Table 54. Pharming Group Recent Developments
Table 55. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Basic Information
Table 56. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Overview
Table 57. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment SWOT Analysis
Table 59. Shire plc (Takeda Pharmaceutical Company Limited) Business Overview
Table 60. Shire plc (Takeda Pharmaceutical Company Limited) Recent Developments
Table 61. Ionis Pharmaceuticals Hereditary Angioedema Treatment Basic Information
Table 62. Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Overview
Table 63. Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Ionis Pharmaceuticals Business Overview
Table 65. Ionis Pharmaceuticals Recent Developments
Table 66. Attune Pharmaceuticals Hereditary Angioedema Treatment Basic Information
Table 67. Attune Pharmaceuticals Hereditary Angioedema Treatment Product Overview
Table 68. Attune Pharmaceuticals Hereditary Angioedema Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Attune Pharmaceuticals Business Overview
Table 70. Attune Pharmaceuticals Recent Developments
Table 71. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Basic Information
Table 72. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Overview
Table 73. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. BioCryst Pharmaceuticals Business Overview
Table 75. BioCryst Pharmaceuticals Recent Developments
Table 76. KalVista Pharmaceuticals Hereditary Angioedema Treatment Basic Information
Table 77. KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Overview
Table 78. KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. KalVista Pharmaceuticals Business Overview
Table 80. KalVista Pharmaceuticals Recent Developments
Table 81. Global Hereditary Angioedema Treatment Sales Forecast by Region (2025-2030) & (Kilotons)
Table 82. Global Hereditary Angioedema Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 83. North America Hereditary Angioedema Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 84. North America Hereditary Angioedema Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 85. Europe Hereditary Angioedema Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 86. Europe Hereditary Angioedema Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 87. Asia Pacific Hereditary Angioedema Treatment Sales Forecast by Region (2025-2030) & (Kilotons)
Table 88. Asia Pacific Hereditary Angioedema Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 89. South America Hereditary Angioedema Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 90. South America Hereditary Angioedema Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 91. Middle East and Africa Hereditary Angioedema Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 92. Middle East and Africa Hereditary Angioedema Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 93. Global Hereditary Angioedema Treatment Sales Forecast by Type (2025-2030) & (Kilotons)
Table 94. Global Hereditary Angioedema Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 95. Global Hereditary Angioedema Treatment Price Forecast by Type (2025-2030) & (USD/Ton)
Table 96. Global Hereditary Angioedema Treatment Sales (Kilotons) Forecast by Application (2025-2030)
Table 97. Global Hereditary Angioedema Treatment Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hereditary Angioedema Treatment Market Size Comparison by Region (M USD)
Table 5. Global Hereditary Angioedema Treatment Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Hereditary Angioedema Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Hereditary Angioedema Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Hereditary Angioedema Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Treatment as of 2022)
Table 10. Global Market Hereditary Angioedema Treatment Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Hereditary Angioedema Treatment Sales Sites and Area Served
Table 12. Manufacturers Hereditary Angioedema Treatment Product Type
Table 13. Global Hereditary Angioedema Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hereditary Angioedema Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hereditary Angioedema Treatment Market Challenges
Table 22. Global Hereditary Angioedema Treatment Sales by Type (Kilotons)
Table 23. Global Hereditary Angioedema Treatment Market Size by Type (M USD)
Table 24. Global Hereditary Angioedema Treatment Sales (Kilotons) by Type (2019-2024)
Table 25. Global Hereditary Angioedema Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Hereditary Angioedema Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Hereditary Angioedema Treatment Market Size Share by Type (2019-2024)
Table 28. Global Hereditary Angioedema Treatment Price (USD/Ton) by Type (2019-2024)
Table 29. Global Hereditary Angioedema Treatment Sales (Kilotons) by Application
Table 30. Global Hereditary Angioedema Treatment Market Size by Application
Table 31. Global Hereditary Angioedema Treatment Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Hereditary Angioedema Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Hereditary Angioedema Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Hereditary Angioedema Treatment Market Share by Application (2019-2024)
Table 35. Global Hereditary Angioedema Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Hereditary Angioedema Treatment Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Hereditary Angioedema Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Hereditary Angioedema Treatment Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Hereditary Angioedema Treatment Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Hereditary Angioedema Treatment Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Hereditary Angioedema Treatment Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Hereditary Angioedema Treatment Sales by Region (2019-2024) & (Kilotons)
Table 43. CSL Hereditary Angioedema Treatment Basic Information
Table 44. CSL Hereditary Angioedema Treatment Product Overview
Table 45. CSL Hereditary Angioedema Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. CSL Business Overview
Table 47. CSL Hereditary Angioedema Treatment SWOT Analysis
Table 48. CSL Recent Developments
Table 49. Pharming Group Hereditary Angioedema Treatment Basic Information
Table 50. Pharming Group Hereditary Angioedema Treatment Product Overview
Table 51. Pharming Group Hereditary Angioedema Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Pharming Group Business Overview
Table 53. Pharming Group Hereditary Angioedema Treatment SWOT Analysis
Table 54. Pharming Group Recent Developments
Table 55. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Basic Information
Table 56. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Overview
Table 57. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment SWOT Analysis
Table 59. Shire plc (Takeda Pharmaceutical Company Limited) Business Overview
Table 60. Shire plc (Takeda Pharmaceutical Company Limited) Recent Developments
Table 61. Ionis Pharmaceuticals Hereditary Angioedema Treatment Basic Information
Table 62. Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Overview
Table 63. Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Ionis Pharmaceuticals Business Overview
Table 65. Ionis Pharmaceuticals Recent Developments
Table 66. Attune Pharmaceuticals Hereditary Angioedema Treatment Basic Information
Table 67. Attune Pharmaceuticals Hereditary Angioedema Treatment Product Overview
Table 68. Attune Pharmaceuticals Hereditary Angioedema Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Attune Pharmaceuticals Business Overview
Table 70. Attune Pharmaceuticals Recent Developments
Table 71. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Basic Information
Table 72. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Overview
Table 73. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. BioCryst Pharmaceuticals Business Overview
Table 75. BioCryst Pharmaceuticals Recent Developments
Table 76. KalVista Pharmaceuticals Hereditary Angioedema Treatment Basic Information
Table 77. KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Overview
Table 78. KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. KalVista Pharmaceuticals Business Overview
Table 80. KalVista Pharmaceuticals Recent Developments
Table 81. Global Hereditary Angioedema Treatment Sales Forecast by Region (2025-2030) & (Kilotons)
Table 82. Global Hereditary Angioedema Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 83. North America Hereditary Angioedema Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 84. North America Hereditary Angioedema Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 85. Europe Hereditary Angioedema Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 86. Europe Hereditary Angioedema Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 87. Asia Pacific Hereditary Angioedema Treatment Sales Forecast by Region (2025-2030) & (Kilotons)
Table 88. Asia Pacific Hereditary Angioedema Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 89. South America Hereditary Angioedema Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 90. South America Hereditary Angioedema Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 91. Middle East and Africa Hereditary Angioedema Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 92. Middle East and Africa Hereditary Angioedema Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 93. Global Hereditary Angioedema Treatment Sales Forecast by Type (2025-2030) & (Kilotons)
Table 94. Global Hereditary Angioedema Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 95. Global Hereditary Angioedema Treatment Price Forecast by Type (2025-2030) & (USD/Ton)
Table 96. Global Hereditary Angioedema Treatment Sales (Kilotons) Forecast by Application (2025-2030)
Table 97. Global Hereditary Angioedema Treatment Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Hereditary Angioedema Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hereditary Angioedema Treatment Market Size (M USD), 2019-2030
Figure 5. Global Hereditary Angioedema Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Hereditary Angioedema Treatment Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hereditary Angioedema Treatment Market Size by Country (M USD)
Figure 11. Hereditary Angioedema Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Hereditary Angioedema Treatment Revenue Share by Manufacturers in 2023
Figure 13. Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hereditary Angioedema Treatment Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hereditary Angioedema Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hereditary Angioedema Treatment Market Share by Type
Figure 18. Sales Market Share of Hereditary Angioedema Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Hereditary Angioedema Treatment by Type in 2023
Figure 20. Market Size Share of Hereditary Angioedema Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Hereditary Angioedema Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hereditary Angioedema Treatment Market Share by Application
Figure 24. Global Hereditary Angioedema Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Hereditary Angioedema Treatment Sales Market Share by Application in 2023
Figure 26. Global Hereditary Angioedema Treatment Market Share by Application (2019-2024)
Figure 27. Global Hereditary Angioedema Treatment Market Share by Application in 2023
Figure 28. Global Hereditary Angioedema Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Hereditary Angioedema Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Hereditary Angioedema Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Hereditary Angioedema Treatment Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Hereditary Angioedema Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Hereditary Angioedema Treatment Sales Market Share by Country in 2023
Figure 37. Germany Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Hereditary Angioedema Treatment Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Hereditary Angioedema Treatment Sales Market Share by Region in 2023
Figure 44. China Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Hereditary Angioedema Treatment Sales and Growth Rate (Kilotons)
Figure 50. South America Hereditary Angioedema Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Hereditary Angioedema Treatment Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Hereditary Angioedema Treatment Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Hereditary Angioedema Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Hereditary Angioedema Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Hereditary Angioedema Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Hereditary Angioedema Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Hereditary Angioedema Treatment Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Hereditary Angioedema Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hereditary Angioedema Treatment Market Size (M USD), 2019-2030
Figure 5. Global Hereditary Angioedema Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Hereditary Angioedema Treatment Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hereditary Angioedema Treatment Market Size by Country (M USD)
Figure 11. Hereditary Angioedema Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Hereditary Angioedema Treatment Revenue Share by Manufacturers in 2023
Figure 13. Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hereditary Angioedema Treatment Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hereditary Angioedema Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hereditary Angioedema Treatment Market Share by Type
Figure 18. Sales Market Share of Hereditary Angioedema Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Hereditary Angioedema Treatment by Type in 2023
Figure 20. Market Size Share of Hereditary Angioedema Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Hereditary Angioedema Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hereditary Angioedema Treatment Market Share by Application
Figure 24. Global Hereditary Angioedema Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Hereditary Angioedema Treatment Sales Market Share by Application in 2023
Figure 26. Global Hereditary Angioedema Treatment Market Share by Application (2019-2024)
Figure 27. Global Hereditary Angioedema Treatment Market Share by Application in 2023
Figure 28. Global Hereditary Angioedema Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Hereditary Angioedema Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Hereditary Angioedema Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Hereditary Angioedema Treatment Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Hereditary Angioedema Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Hereditary Angioedema Treatment Sales Market Share by Country in 2023
Figure 37. Germany Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Hereditary Angioedema Treatment Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Hereditary Angioedema Treatment Sales Market Share by Region in 2023
Figure 44. China Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Hereditary Angioedema Treatment Sales and Growth Rate (Kilotons)
Figure 50. South America Hereditary Angioedema Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Hereditary Angioedema Treatment Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Hereditary Angioedema Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Hereditary Angioedema Treatment Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Hereditary Angioedema Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Hereditary Angioedema Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Hereditary Angioedema Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Hereditary Angioedema Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Hereditary Angioedema Treatment Market Share Forecast by Application (2025-2030)
